Impact Advisory Board
The Impact Advisory Board (IAB) provides thought leadership and research expertise to guide Family Reach as we measure our impact on the financial burden of cancer. In order to provide comprehensive and meaningful services for patients and caregivers, Family Reach conducts ongoing measurement and evaluation of our services, including stakeholder surveys, literature reviews, intervention analyses, and focus groups. The Impact Advisory Board advises Family Reach on the strategy, design and delivery of these initiatives to ensure success in our data collection, analysis, and program improvements. The IAB also offers, contributes and reacts to new ideas that further enhance our mission of removing financial barriers to treatment in an equitable and accessible manner.

Peter C. Adamson, MD
Children’s Hospital of Philadelphia
Children’s Oncology Group
Blue Ribbon Panel, National Cancer Moonshot

Kira Bona, MD, MPH
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Joe Chabot, MS
Dana-Farber/Boston Children’s Cancer & Blood Disorders Center

Lorraine T. Dean, ScD
Johns Hopkins Bloomberg School of Public Health

Elizabeth Franklin, PhD, MSW
Sanofi

David Hong, MD
MD Anderson Cancer Center

Ryan Nipp, MD
Harvard Medical School
Massachusetts General Hospital

Scott Ramsey, MD
Fred Hutchinson Cancer Research Center
University of Washington Medical Center

Veena Shankaran, MD
Fred Hutchinson Cancer Research Center
University of Washington Medical Center
Seattle Cancer Care Alliance

Lillie D. Shockney, RN
John Hopkins Breast Center
Association of Oncology Nurse Navigators

Jonas de Souza, MD
Humana
Patient Access Network Foundation

Yousuf Zafar, MD
Duke Cancer Center